Tech Launch Arizona

Submit a New Inquiry

Technology #ua16-144 - Development of Glycosylated Derivatives of the Neuropeptide PACAP for the Treatment of Neurodegenerative Disease and Migraine

Tech Launch Arizona contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.

Optional

Optional

By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant